{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T11:12:23Z","timestamp":1778584343271,"version":"3.51.4"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Non-alcoholic steatohepatitis (NASH)-related liver cancer (LC), attributable to metabolic risk factors, is a significant global health challenge. This study investigates its burden from 1990 to 2021, focusing on temporal trends, geographic disparities, and demographic patterns, with projections to 2050.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We analyzed data from the Global Burden of Disease 2021. Disability-adjusted life years (DALYs) and deaths were quantified by sex, age, and sociodemographic index (SDI) quintiles. Decomposition, age\u2013period\u2013cohort, and Bayesian modeling were employed to evaluate drivers and project trends.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>From 1990 to 2021, global DALYs and deaths due to NASH-related LC attributable to metabolic risk factors nearly tripled, with the DALY age-standardized rate (ASR) rising by 81.2% (95% CI: 60.2\u2013105.1%) and the death ASR by 90.9% (95% CI: 67.4\u2013116.3%). High-SDI countries had the highest ASRs, but low\/low-middle-SDI regions saw the fastest growth, particularly among younger populations. Males bore a higher burden, though female rates increased faster in older groups. Epidemiological changes (41.8%), aging (29.5%), and population growth (28.7%) drove DALY increases. Projections suggest DALYs and deaths will nearly triple by 2050, shifting toward older ages.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The global burden of NASH-related LC is increasing sharply, with significant temporal, geographic, and demographic disparities. These trends pose an escalating challenge for surgical systems, necessitating strategic investment in hepatobiliary surgical capacity, perioperative infrastructure, and preventive public health measures \u2013 particularly for aging, comorbid populations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/js9.0000000000003814","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T09:00:15Z","timestamp":1764061215000},"page":"2507-2517","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["The liver cancer due to non-alcoholic steatohepatitis attributable to metabolic risk factors in 204 countries and territories, 1990\u20132021: an age\u2013period\u2013cohort analysis from the Global Burden of Disease study"],"prefix":"10.1097","volume":"112","author":[{"given":"Yuanyuan","family":"Ye","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Metabolism, Tianjin Medical University General Hospital, Tianjin, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziping","family":"Li","sequence":"additional","affiliation":[{"name":"National Clinical Research Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yian","family":"Gu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Tianjin Medical University General Hospital, Tianjin, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mi","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, Tianjin Medical University General Hospital, Tianjin, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Tianjin Medical University General Hospital, Tianjin, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,10,28]]},"reference":[{"key":"R1-20260512","doi-asserted-by":"crossref","first-page":"11\u201320","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R2-20260512","doi-asserted-by":"crossref","first-page":"531\u201344","DOI":"10.1016\/j.jhep.2018.10.033","article-title":"Non-alcoholic fatty liver disease - A global public health perspective","volume":"70","author":"Younossi","year":"2019","journal-title":"J Hepatol"},{"key":"R3-20260512","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1053\/j.gastro.2021.04.074","article-title":"Preparing for the NASH epidemic: a call to action","volume":"161","author":"Kanwal","year":"2021","journal-title":"Gastroenterology"},{"key":"R4-20260512","doi-asserted-by":"crossref","first-page":"330\u201344","DOI":"10.1038\/nrgastro.2013.41","article-title":"Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis","volume":"10","author":"Anstee","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R5-20260512","doi-asserted-by":"crossref","first-page":"2410\u201323","DOI":"10.1002\/hep.31845","article-title":"Cancer risk in patients with biopsy-confirmed nonalcoholic fatty liver disease: a population-based cohort study","volume":"74","author":"Simon","year":"2021","journal-title":"Hepatology"},{"key":"R6-20260512","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.cgh.2021.05.002","article-title":"Incidence of hepatocellular carcinoma in patients with nonalcoholic fatty liver disease: a systematic review, meta-analysis, and meta-regression","volume":"20","author":"Orci","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R7-20260512","doi-asserted-by":"crossref","first-page":"313\u201324","DOI":"10.1016\/j.cld.2015.10.010","article-title":"Progression and natural history of nonalcoholic fatty liver disease in adults","volume":"20","author":"Marengo","year":"2016","journal-title":"Clin Liver Dis"},{"key":"R8-20260512","doi-asserted-by":"crossref","first-page":"2361\u201382","DOI":"10.3748\/wjg.v28.i21.2361","article-title":"Socioeconomics and attributable etiology of primary liver cancer, 1990-2019","volume":"28","author":"Xing","year":"2022","journal-title":"World J Gastroenterol"},{"key":"R9-20260512","doi-asserted-by":"crossref","first-page":"1229\u201336","DOI":"10.1016\/j.jhep.2019.08.018","article-title":"The risk of incident extrahepatic cancers is higher in non-alcoholic fatty liver disease than obesity - A longitudinal cohort study","volume":"71","author":"Allen","year":"2019","journal-title":"J Hepatol"},{"key":"R10-20260512","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.medj.2023.02.002","article-title":"Global burden of common cancers attributable to metabolic risks from 1990 to 2019","volume":"4","author":"Xing","year":"2023","journal-title":"Med"},{"key":"R11-20260512","doi-asserted-by":"crossref","first-page":"564\u201372","DOI":"10.1002\/hep.30254","article-title":"Burden of illness and economic model for patients with nonalcoholic steatohepatitis in the united states","volume":"69","author":"Younossi","year":"2019","journal-title":"Hepatology"},{"key":"R12-20260512","doi-asserted-by":"crossref","first-page":"487\u2013503","DOI":"10.1038\/s41575-023-00754-7","article-title":"Nonalcoholic steatohepatitis-related hepatocellular carcinoma: pathogenesis and treatment","volume":"20","author":"Llovet","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R13-20260512","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.jacc.2019.08.565","article-title":"Liver resection for nonalcoholic fatty liver disease-associated hepatocellular carcinoma","volume":"229","author":"Koh","year":"2019","journal-title":"J Am Coll Surg"},{"key":"R14-20260512","doi-asserted-by":"crossref","first-page":"2253\u201361","DOI":"10.1245\/s10434-014-4221-5","article-title":"Impact of steatosis on prognosis of patients with early-stage hepatocellular carcinoma after hepatic resection","volume":"22","author":"Su","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"R15-20260512","doi-asserted-by":"crossref","first-page":"2133\u201361","DOI":"10.1016\/S0140-6736(24)00757-8","article-title":"Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the global burden of disease study 2021","volume":"403","author":"Ferrari","year":"2024","journal-title":"Lancet"},{"key":"R16-20260512","doi-asserted-by":"crossref","first-page":"2162\u2013203","DOI":"10.1016\/S0140-6736(24)00933-4","article-title":"Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the global burden of disease study 2021","volume":"403","author":"Brauer","year":"2024","journal-title":"Lancet"},{"key":"R17-20260512","doi-asserted-by":"crossref","first-page":"112023","DOI":"10.1016\/j.envres.2021.112023","article-title":"Global burden of lung cancer attributable to ambient fine particulate matter pollution in 204 countries and territories, 1990-2019","volume":"204","author":"Yang","year":"2022","journal-title":"Environ Res"},{"key":"R18-20260512","first-page":"100081","article-title":"Revised strengthening the reporting of cohort, cross-sectional and case-control studies in surgery (STROCSS) guideline: an update for the age of Artificial Intelligence","volume":"10","author":"Agha","year":"2025","journal-title":"Premier J Sci"},{"key":"R19-20260512","doi-asserted-by":"crossref","first-page":"208\u201317","DOI":"10.1080\/03014460.2019.1707872","article-title":"Age period cohort analysis: a review of what we should and shouldn\u2019t do","volume":"47","author":"Bell","year":"2020","journal-title":"Ann Hum Biol"},{"key":"R20-20260512","doi-asserted-by":"crossref","first-page":"790\u201399","DOI":"10.1161\/CIRCULATIONAHA.119.042864","article-title":"Time trends in cardiovascular disease mortality across the BRICS: an age-period-cohort analysis of key nations with emerging economies using the global burden of disease study 2017","volume":"141","author":"Zou","year":"2020","journal-title":"Circulation"},{"key":"R21-20260512","doi-asserted-by":"crossref","first-page":"2084\u201392","DOI":"10.1016\/S0140-6736(21)02178-4","article-title":"The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: a register-based observational study","volume":"398","author":"Falcaro","year":"2021","journal-title":"Lancet"},{"key":"R22-20260512","doi-asserted-by":"crossref","first-page":"2296\u2013302","DOI":"10.1158\/1055-9965.EPI-14-0300","article-title":"A web tool for age-period-cohort analysis of cancer incidence and mortality rates","volume":"23","author":"Rosenberg","year":"2014","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R23-20260512","doi-asserted-by":"crossref","first-page":"e1003138","DOI":"10.1371\/journal.pmed.1003138","article-title":"Population ageing and mortality during 1990-2017: a global decomposition analysis","volume":"17","author":"Cheng","year":"2020","journal-title":"PLoS Med"},{"key":"R24-20260512","first-page":"171","article-title":"Standardization and decomposition of rates from cross-classified data","volume":"50","author":"Das Gupta","year":"1994","journal-title":"Genus"},{"key":"R26-20260512","doi-asserted-by":"crossref","first-page":"128\u201342","DOI":"10.1093\/ije\/dyaa196","article-title":"Global trend of aetiology-based primary liver cancer incidence from 1990 to 2030: a modelling study","volume":"50","author":"Liu","year":"2021","journal-title":"Int J Epidemiol"},{"key":"R27-20260512","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s40364-020-00195-3","article-title":"Trends and projections of kidney cancer incidence at the global and national levels, 1990-2030: a Bayesian age-period-cohort modeling study","volume":"8","author":"Du","year":"2020","journal-title":"Biomark Res"},{"key":"R28-20260512","doi-asserted-by":"crossref","first-page":"862\u201373","DOI":"10.1016\/j.jhep.2017.06.003","article-title":"New trends on obesity and NAFLD in Asia","volume":"67","author":"Fan","year":"2017","journal-title":"J Hepatol"},{"key":"R29-20260512","doi-asserted-by":"crossref","first-page":"278\u2013316","DOI":"10.1210\/er.2015-1137","article-title":"Sex and gender differences in risk, pathophysiology and complications of type 2 diabetes mellitus","volume":"37","author":"Kautzky-Willer","year":"2016","journal-title":"Endocr Rev"},{"key":"R30-20260512","doi-asserted-by":"crossref","first-page":"e081221198651","DOI":"10.2174\/1573399818666211208110759","article-title":"Type 2 diabetes in women: differences and difficulties","volume":"18","author":"Kesavadev","year":"2022","journal-title":"Curr Diabetes Rev"},{"key":"R31-20260512","doi-asserted-by":"crossref","first-page":"1761\u201372","DOI":"10.1007\/s00125-019-4939-5","article-title":"Sex differences in the burden of type 2 diabetes and cardiovascular risk across the life course","volume":"62","author":"Huebschmann","year":"2019","journal-title":"Diabetologia"},{"key":"R32-20260512","doi-asserted-by":"crossref","first-page":"e340","DOI":"10.1016\/S2666-7568(21)00089-1","article-title":"The state of diabetes treatment coverage in 55 low-income and middle-income countries: a cross-sectional study of nationally representative, individual-level data in 680 102 adults","volume":"2","author":"Flood","year":"2021","journal-title":"Lancet Healthy Longev"},{"key":"R33-20260512","doi-asserted-by":"crossref","first-page":"896\u2013904","DOI":"10.1016\/j.jhep.2018.05.036","article-title":"Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030","volume":"69","author":"Estes","year":"2018","journal-title":"J Hepatol"},{"key":"R34-20260512","doi-asserted-by":"crossref","first-page":"1559\u201369","DOI":"10.1056\/NEJMoa2029349","article-title":"Prospective study of outcomes in adults with nonalcoholic fatty liver disease","volume":"385","author":"Sanyal","year":"2021","journal-title":"N Engl J Med"},{"key":"R35-20260512","doi-asserted-by":"crossref","first-page":"562\u201373","DOI":"10.1038\/s41591-023-02242-6","article-title":"Challenges and opportunities in NASH drug development","volume":"29","author":"Harrison","year":"2023","journal-title":"Nat Med"},{"key":"R36-20260512","doi-asserted-by":"crossref","first-page":"1175\u201383","DOI":"10.1001\/jama.2020.2298","article-title":"Nonalcoholic steatohepatitis: a review","volume":"323","author":"Sheka","year":"2020","journal-title":"Jama"}],"container-title":["International Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000003814","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T10:29:15Z","timestamp":1778581755000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000003814"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,28]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/js9.0000000000003814","relation":{},"ISSN":["1743-9159"],"issn-type":[{"value":"1743-9159","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,28]]},"assertion":[{"value":"2025-07-03","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-12","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}